Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
Authors:
Top Cited Papers
- 1 April 2015
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 27 (4) , 589-602
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NIH) grant R01 (1R01CA160467)
- NIH T32 (HD007505, GM007315)
- Leukemia and Lymphoma Society (LLS) TRP grant (6116-12)
- LLS Scholar (1215-14)
- LLS Therapy Acceleration Program
- American Cancer Society (RSG-11-082-01-DMC, RSG-13-130-01-CDD)
- Department of Pathology, University of Michigan
- USA Department of Energy, Office of Science, Office of Basic Energy Sciences (DE-AC02-06CH11357)
- Michigan Economic Development Corporation
- Michigan Technology Tri-Corridor (085P1000817)
This publication has 35 references indexed in Scilit:
- Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemiaNature Chemical Biology, 2012
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaNature, 2011
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1LCancer Cell, 2011
- Molecular Basis of the Mixed Lineage Leukemia-Menin InteractionJournal of Biological Chemistry, 2010
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid LeukemiaCancer Cell, 2010
- Menin regulates the function of hematopoietic stem cells and lymphoid progenitorsBlood, 2009
- Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemiaGenes & Development, 2008
- Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target GenesCancer Cell, 2008
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006